e31
a70
e31
a70
e31
a70
b47
e31
a70
e31
a70
e31
a70
e31
a70
15466206
PubMed
BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis.
Cancer Res
2004
Wilhelm SM
Carter C
Tang L
Wilkie D
McNabola A
Rong H
Chen C
Zhang X
Vincent P
McHugh M
Cao Y
Shujath J
Gawlak S
Eveleigh D
Rowley B
Liu L
Adnane L
Lynch M
Auclair D
Taylor I
Gedrich R
Voznesensky A
Riedl B
Post LE
Bollag G
Trail PA
17016424
PubMed
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer.
Nat Rev Drug Discov
2006
Wilhelm S
Carter C
Lynch M
Lowinger T
Dumas J
Smith RA
Schwartz B
Simantov R
Kelley S
16507829
PubMed
BAY 43-9006 inhibition of oncogenic RET mutants.
J Natl Cancer Inst
2006
Carlomagno F
Anaganti S
Guida T
Salvatore G
Troncone G
Wilhelm SM
Santoro M